Literature DB >> 19399939

Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis.

Xiao-Li Chen1, Sang-Zhu Ciren, Hui Zhang, Li-Geng Duan, Alexander J Wesley.   

Abstract

AIM: To investigate the effects of 5-Fluorouracil (5-FU) on modulation of pro-inflammatory and anti-inflammatory cytokines in acute pancreatitis and the mechanism of it in the treatment of acute pancreatitis.
METHODS: Male Sprague Dawley rats were assigned to 3 Groups: Group A, sham operated rats as controls (n = 7); Group B, acute pancreatitis induced by ductal injection with 5% sodium cholate at a volume of 1.0 mL/kg without any other treatment; Group C, after the pancreatitis was induced as in Group B, the rats were injected intravenously with 5-FU 40 mg/kg. The animals in Groups B and C were killed at 2, 6 and 24 h after operation (n = 7), and blood samples were taken for measurement of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), interleukin-6 (IL-6) (by bioassay), and interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta) (by ELISA). The wet weight of pancreatic tissue, serum amylase levels and white blood cells were also measured.
RESULTS: Four rats in Group B and one in Group C died after pancreatitis was induced. Both pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) at the 2 and 6 h period and the anti-inflammatory cytokines (IL-10, TGF-beta) at 24 h increased significantly (P < 0.05) in rats of Group B. After treatment with 5-FU, TNF-alpha, IL-1, and IL-6 in serum of rats of Group C were inhibited at 2 and 6 h after operation (P < 0.05), and IL-10, TGF-beta were inhibited at 24 h compared to Group B (P < 0.05). Obvious improvements in the severity of the acute pancreatitis, including the amylase levels, wet weight of pancreatic tissue and neutrophil counts, were also observed after treatment with 5-FU.
CONCLUSION: 5-FU is an anti-metabolic and immunosuppressive agent which can minimize the abnormal immune cytokine response and relieve the pathophysiological disorders associated with experimental acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399939      PMCID: PMC2675097          DOI: 10.3748/wjg.15.2032

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

Review 1.  [Cytokine imbalance in critically ill patients: SIRS and CARS].

Authors:  A Murata; M Kikuchi; S Mishima; S Sakaki; H Goto; T Matsuoka; H Tanaka; T Yukioka; S Shimazaki
Journal:  Nihon Geka Gakkai Zasshi       Date:  1999-07

Review 2.  The potential role of therapeutic cytokine manipulation in acute pancreatitis.

Authors:  W Denham; J Norman
Journal:  Surg Clin North Am       Date:  1999-08       Impact factor: 2.741

Review 3.  MODS/SIRS: result of an overwhelming inflammatory response?

Authors:  R J Goris
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

4.  A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits.

Authors:  M O Osman; J U Kristensen; N O Jacobsen; S B Lausten; B Deleuran; M Deleuran; B Gesser; K Matsushima; C G Larsen; S L Jensen
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

5.  Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis.

Authors:  F G Brivet; D Emilie; P Galanaud
Journal:  Crit Care Med       Date:  1999-04       Impact factor: 7.598

Review 6.  Mediators of injury and inflammation.

Authors:  G Schlag; H Redl
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

7.  Increased monocyte cytokine production in association with systemic complications in acute pancreatitis.

Authors:  C J McKay; G Gallagher; B Brooks; C W Imrie; J N Baxter
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

8.  [Local arterial infusion of 5-FU in treatment of acute necrotic pancreatitis].

Authors:  F Gu; Y Liu; R Pan
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1995-06

9.  Decreased mortality of severe acute pancreatitis after proximal cytokine blockade.

Authors:  J G Norman; M G Franz; G S Fink; J Messina; P J Fabri; W R Gower; L C Carey
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

Authors:  C J Fisher; J M Agosti; S M Opal; S F Lowry; R A Balk; J C Sadoff; E Abraham; R M Schein; E Benjamin
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  3 in total

Review 1.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

2.  Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model.

Authors:  Meng Tao Zhou; Bi Cheng Chen; Hong Wei Sun; Yue Peng Jin; Fa Jing Yang; Xing Zhang; Roland Andersson; Qi Yu Zhang
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

3.  Predicting Efficacy of 5-Fluorouracil Therapy via a Mathematical Model with Fuzzy Uncertain Parameters.

Authors:  Sajad Shafiekhani; Amir Homayoun Jafari; Leila Jafarzadeh; Vahid Sadeghi; Nematollah Gheibi
Journal:  J Med Signals Sens       Date:  2022-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.